Fibrinogen measurements in plasma and whole blood: A performance evaluation study of the dry-hematology system

Anesthesia and Analgesia

Volumn 120, Issue 1, 2015, Pages 18-25

  Ogawa, Satoru ^a   Tanaka, Kenichi A ^b   Nakajima, Yasufumi ^a   Nakayama, Yoshinobu ^a   Takeshita, Jun ^a   Arai, Masatoshi ^c   Mizobe, Toshiki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c R and D for Diagnostics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIGEN; FIBRINOGEN; HEPARIN; HETASTARCH; HUMAN ALBUMIN; SODIUM CHLORIDE;

ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRY HEMATOLOGY METHOD; EVALUATION STUDY; EX VIVO STUDY; FIBRIN FORMATION; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; HEMATOLOGY; HUMAN; HYPOFIBRINOGENEMIA; IN VITRO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT ACCURACY; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTHROMBIN TIME; SURGICAL PATIENT; TURNAROUND TIME; AGED; CHEMISTRY; DEVICES; FEMALE; HEART SURGERY; MALE; PATIENT; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY;

AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; FIBRINOGEN; HEALTHY VOLUNTEERS; HEMATOLOGY; HUMANS; MALE; PATIENTS; PLASMA; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84924065301     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000448     Document Type: Article

References (33)

1. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014;54:1389-405
2. Clark RA. Fibrin and wound healing. Ann N Y Acad Sci 2001;936:355-67
3. Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010;104:318-25
4. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, Saggau W. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93:1101-7
5. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010;113:1205-19
6. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012;114:261-74
7. CLAUSS A. Rapid physiological coagulation method in determination of fibrinogen [in German]. Acta Haematol 1957;17:237-46
8. Mackie J, Lawrie AS, Kitchen S, Gaffney PJ, Howarth D, Lowe GD, Martin J, Purdy G, Rigsby P, Rumley A. A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost 2002;87:997-1005
9. Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res 2010;126:e428-33
10. Solomon C, Cadamuro J, Ziegler B, Schöchl H, Varvenne M, SØrensen B, Hochleitner G, Rahe-Meyer N. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011;51:1695-706
11. Tanaka KA, Bader SO, Sturgil EL. Diagnosis of perioperative coagulopathy-plasma versus whole blood testing. J Cardiothorac Vasc Anesth 2013;27:S9-15
12. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, SØrensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010;50:2571-6
13. Gertler R, Wiesner G, Tassani-Prell P, Braun SL, Martin K. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine? J Cardiothorac Vasc Anesth 2011;25:981-6
14. Solomon C, SØrensen B, Hochleitner G, Kashuk J, Ranucci M, Schöchl H. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012;114:721-30
15. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012;26:1-13
16. Oberhardt BJ, Dermott SC, Taylor M, Alkadi ZY, Abruzzini AF, Gresalfi NJ. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem 1991;37:520-6
17. Gosselin RC, Owings JT, Pollock ME, Larkin E. Evaluation of a point-of-care coagulation device, the thrombolytic assessment system (TAS), for measuring prothrombin times, activated partial thromboplastin times, and high-dose heparin anticoagulation. Lab Hematol 1998;4: 217-24
18. Amukele TK, Ferrell C, Chandler WL. Comparison of plasma with whole blood prothrombin time and fibrinogen on the same instrument. Am J Clin Pathol 2010;133:550-6
19. Ogawa S, Szlam F, Bolliger D, Nishimura T, Chen EP, Tanaka KA. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry. Anesth Analg 2012;115:16-21
20. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, Levy JH, Tanaka KA. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012;52:14-22
21. Roullet S, Pillot J, Freyburger G, Biais M, Quinart A, Rault A, Revel P, Sztark F. Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation. Br J Anaesth 2010;104:422-8
22. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68
23. McBride GB. A proposal for strength-of-Agreement criteria for Lin's concordance correlation coefficient. NIWA Client Report. HAM2005-062.2005;1-10
24. Myles PS, Cui J. Using the Bland-Altman method to measure agreement with repeated measures. Br J Anaesth 2007;99: 309-11
25. Bland JM, Altman DG. Agreed statistics: measurement method comparison. Anesthesiology 2012;116:182-5
26. Lawrie AS, McDonald SJ, Purdy G, Mackie IJ, Machin SJ. Prothrombin time derived fibrinogen determination on Sysmex CA-6000. J Clin Pathol 1998;51:462-6
27. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995;6:743-6
28. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106:1366-75
29. Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012;117: 531-47
30. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14:R55
31. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012;109:851-63
32. Nielsen VG, Gurley WQ Jr, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004;99:120-3
33. Jámbor C, Reul V, Schnider TW, Degiacomi P, Metzner H, Korte WC. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Anesth Analg 2009;109:1023-8